Nafithromycin
- Generic Name
- Nafithromycin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C42H62N6O11S
- CAS Number
- 1691240-78-4
- Unique Ingredient Identifier
- 75F74Y2R70
- Background
Nafithromycin is under investigation in clinical trial NCT02903836 (Phase II Study of Oral Nafithromycin in CABP).
- Associated Conditions
- -
- Associated Therapies
- -
Safety, Tolerability, and Pharmacokinetics of Multiple Doses of Intravenous Nafithromycin
- First Posted Date
- 2019-06-11
- Last Posted Date
- 2019-10-02
- Lead Sponsor
- Wockhardt
- Target Recruit Count
- 10
- Registration Number
- NCT03981887
- Locations
- 🇺🇸
Spaulding Clinical Research, West Bend, Wisconsin, United States
A Phase 1 Pharmacokinetic Study of Single-Ascending Doses of Intravenous Nafithromycin in Healthy Adult Subjects
- First Posted Date
- 2016-05-12
- Last Posted Date
- 2018-08-01
- Lead Sponsor
- Wockhardt
- Target Recruit Count
- 60
- Registration Number
- NCT02770404
- Locations
- 🇺🇸
Phase 1 unit : Spaulding Clinical Research, LLC, West Bend, Wisconsin, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath